1Cabre A, Lazaro I, Girona J,et al. Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis, 2007, 195 : e150- e158.
2Yeung DCY, Xu A, Cheung CWS, et al. Serum adipocyte fatty acid-binding protein levels wereIndependently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol, 2007, 27:1796-1802.
3Annette WK,Carolh HY,Aimin X, et al. Serum adipocyte fatty acid-binding protein as a new biomarker predicting the development of type 2 Diabetes. Diabete Care, 2007, 30 (10) : 2667- 2672.
4Rhee EJ, Lee WY, Park CY,et al. The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults. Eur J Endocrinol, 2009,160, (2):165-172.
